Scandinavia

GKIAB was founded by Tomas Gloveus in 2010. The company is specialized in the Rare Disease segment with special expertise in the Nordic area. Focus areas are Named Patient Usage (NPU) strategy for Orphan Drugs and Sales/Marketing as well as Market Access strategy within the rare disease area.